Thermo Fisher Scientific (TMO) Current Assets (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Current Assets for 18 consecutive years, with $22.3 billion the latest figure, recorded in Q1 2026.

• Current Assets for Q1 2026 came in at $22.3 billion, down 4.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.3 billion (down 4.54% YoY), and the FY2025 annual result was $28.7 billion, up 29.68% from the prior year.
• Current Assets was $22.3 billion for Q1 2026 at Thermo Fisher Scientific, down from $28.7 billion in the prior quarter.
• Over five years, Current Assets peaked at $28.7 billion in Q4 2025 and troughed at $18.1 billion in Q3 2022.
• Average Current Assets over 5 years is $22.7 billion, with a median of $23.1 billion recorded in 2023.
• Year-over-year, Current Assets slipped 21.94% in 2022 and grew 29.68% in 2025.
• Over 5 years, Current Assets stood at $25.2 billion in 2022, then declined by 2.54% to $24.6 billion in 2023, then slipped by 9.97% to $22.1 billion in 2024, then advanced by 29.68% to $28.7 billion in 2025, then dropped by 22.26% to $22.3 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $22.3 billion in Q1 2026, $28.7 billion in Q4 2025, and $22.3 billion in Q3 2025.